Caterino, M.; Pirozzi, M.; Facchini, S.; Zotta, A.; Sica, A.; Lo Giudice, G.; Rauso, R.; Varriale, E.; Ciardiello, F.; Fasano, M.
Sorafenib in Metastatic Papillary Thyroid Carcinoma with BRAF K601E Mutation on Liquid Biopsy: A Case Report and Literature Review. Medicina 2022, 58, 666.
https://doi.org/10.3390/medicina58050666
AMA Style
Caterino M, Pirozzi M, Facchini S, Zotta A, Sica A, Lo Giudice G, Rauso R, Varriale E, Ciardiello F, Fasano M.
Sorafenib in Metastatic Papillary Thyroid Carcinoma with BRAF K601E Mutation on Liquid Biopsy: A Case Report and Literature Review. Medicina. 2022; 58(5):666.
https://doi.org/10.3390/medicina58050666
Chicago/Turabian Style
Caterino, Marianna, Mario Pirozzi, Sergio Facchini, Alessia Zotta, Antonello Sica, Giorgio Lo Giudice, Raffaele Rauso, Elisa Varriale, Fortunato Ciardiello, and Morena Fasano.
2022. "Sorafenib in Metastatic Papillary Thyroid Carcinoma with BRAF K601E Mutation on Liquid Biopsy: A Case Report and Literature Review" Medicina 58, no. 5: 666.
https://doi.org/10.3390/medicina58050666
APA Style
Caterino, M., Pirozzi, M., Facchini, S., Zotta, A., Sica, A., Lo Giudice, G., Rauso, R., Varriale, E., Ciardiello, F., & Fasano, M.
(2022). Sorafenib in Metastatic Papillary Thyroid Carcinoma with BRAF K601E Mutation on Liquid Biopsy: A Case Report and Literature Review. Medicina, 58(5), 666.
https://doi.org/10.3390/medicina58050666
